fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

BAD 2014 Report: Sunlight, skin cancer and vitamin D – getting the balance right

Written by | 25 Jul 2014

by Esther Drain – Skin cancer is now the commonest cancer in the UK and the incidence is rising, mainly due to people taking more holidays in sunny… read more.

ADA 2014 Report: Hope for artificial Pancreas

Written by | 4 Jul 2014

A bihormonal “artificial pancreas” improved glycemic control and led to less hypoglycemia in type 1 diabetes patients, researchers reported here.

Strong link between depression and early death among elderly diabetics

Written by | 24 Jun 2014

People with diabetes have about double the risk of premature death as people of the same age without diabetes. Studies also have shown that they have about twice… read more.

Metformin 500 mg BID does not protect against heart failure after heart attack in non-diabetic patients

Written by | 29 May 2014

by Bruce Sylvester – Metformin therapy at 500 twice daily (BID) is not protective against heart failure in non-diabetic patients following a heart attack, researchers reported on March… read more.

Computer clusters new sub type asthma patients

Written by | 8 May 2014

Analysis could eventually lead to improved therapy, researcher says.  So many variables can contribute to shortness of breath that no person can keep them all straight. But a… read more.

ACC 2014 Report: Bariatric surgery vs. intensive medical therapy for uncontrolled diabetes: STAMPEDE Trial

Written by | 30 Apr 2014

by Bruce Sylvester – For managing uncontrolled type 2 diabetes in obese patients, gastric bypass and sleeve gastrectomy are each more effective than intensive medical therapy alone.

ACC 2014 Report: TAVR Real-world heart results consistent with scientific research

Written by | 29 Apr 2014

Study helps put new TAVR technology in perspective for high-risk patients.  The first one-year outcomes data of transcatheter heart valve replacement (TAVR) in nearly all U.S. patients undergoing… read more.

ACC 2014 Report: Proportion of adults affected by new BP guideline

Written by | 25 Apr 2014

Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that… read more.

ACC 2014 Report: Aleglitaza does not reduce risk of CV events in diabetics

Written by | 23 Apr 2014

Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death,… read more.

BTS Report 2014: 5-year outcomes of a randomized prospective trial (CamTac Trial)

Written by | 22 Apr 2014

Poster Presentation:  Study of alemtuzumab induction with tacrolimus maintenance monotherapy compared to IL2R blockade with tacrolimus/MMF maintenance in kidney transplantation by Adam McLean, Imperial College Kidney & Transplant… read more.

BTS Report 2014: Medawar Medal winner – Poster Presentation

Written by | 22 Apr 2014

Quality assessment of human kidneys using ex-vivo normothermic perfusion by Adam Barlow, University Hospitals of Leicester – Ex-vivo normothermic perfusion is a viable method of preserving kidneys for… read more.

BTS Report 2014: Hypercoagulability in potential pancreas transplant recipients – the value of thromboelastography

Written by | 21 Apr 2014

Maria Dalby reporting on the Oral Presentation by Mari Kilner, Freeman Hospital, Newcastle upon Tyne- Thromboelastography is a method of testing the efficiency of coagulation which measures not… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.